Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary.
Saved in:
| Title: | Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary. |
|---|---|
| Authors: | Posner A; Department of Clinical Pathology and Centre for Cancer Research, The University of Melbourne, Melbourne, Victoria, Australia., Sivakumaran T; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Pattison A; Department of Clinical Pathology and Centre for Cancer Research, The University of Melbourne, Melbourne, Victoria, Australia., Etemadmoghadam D; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Thio N; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Wood C; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Fisher K; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Webb S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., DeFazio A; Department of Gynaecological Oncology, and Westmead Institute for Medical Research, Westmead Hospital, Westmead, New South Wales, Australia.; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia., Wilcken N; Department of Medical Oncology, Westmead Hospital The Crown Princess Mary Cancer Centre, Sydney, New South Wales, Australia., Gao B; Department of Medical Oncology, Westmead Hospital The Crown Princess Mary Cancer Centre, Sydney, New South Wales, Australia., Karapetis CS; Department of Medical Oncology and Flinders Medical Centre, Flinders University, Adelaide, South Australia, Australia., Singh M; Department of Medical Oncology, Barwon Health Cancer Services, Geelong, Victoria, Australia., Collins IM; Department of Medical Oncology and SouthWest HealthCare, Deakin University - Warrnambool Campus, Warrnambool, Victoria, Australia., Richardson G; Medical Oncology, Cabrini Health, Malvern, Victoria, Australia., Steer C; Border Medical Oncology, Albury Wodonga Regional Cancer Centre, Albury, Victoria, Australia., Warren M; Medical Oncology, Bendigo Health, Bendigo, Victoria, Australia., Karanth N; Division of Medicine, Top End Health and Hospital Services, Alan Walker Cancer Centre, Darwin, Northern Territory, Australia., Fellowes A; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Fox SB; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Hicks RJ; St Vincent's Hospital Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia., Schofield P; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Behavioural Sciences Unit, Health Services Research and Implementation Sciences, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Bowtell D; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Prall OWJ; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Tothill RW; Department of Clinical Pathology and Centre for Cancer Research, The University of Melbourne, Melbourne, Victoria, Australia rtothill@unimelb.edu.au Linda.Mileshkin@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Mileshkin L; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia rtothill@unimelb.edu.au Linda.Mileshkin@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jan; Vol. 11 (1). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
